Company Filing History:
1 out of 1 
1 out of 1 
1 out of 8 Years Active: 2020-2022
Title: Innovations and Contributions of Inventor Honghai Gao
Introduction
Honghai Gao is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of three patents to his name, Gao's work has the potential to impact cancer treatment and immunotherapy.
Latest Patents
One of his latest patents is titled "CD47 antigen binding unit and uses thereof." This patent discloses antigen binding units that specifically bind to CD47, along with polynucleic acids encoding these units, vectors comprising said polynucleic acids, and methods for inducing phagocytosis of CD47-expressing cells. Another notable patent is for an "Anti-PD-1 monoclonal antibody, and preparation method therefor and application thereof." This invention describes an anti-human PD-1 monoclonal antibody that effectively binds to the extracellular region of the human PD-1 protein receptor. It has shown promise in enhancing immunity and can be used in tumor immunotherapy and the diagnosis of PD-L1 positive tumors.
Career Highlights
Throughout his career, Honghai Gao has worked with various companies, including Zlip Holding Limited and Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of biotechnology.
Collaborations
Gao has collaborated with notable colleagues such as Jie Zhao and Jinlin Guo. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Honghai Gao's contributions to biotechnology through his innovative patents highlight his role as a significant inventor in the field. His work on therapeutic antibodies has the potential to revolutionize cancer treatment and improve patient outcomes.